ストックスクリーナーアプリを入手
8.60
4.97%
-0.45
前日終値:
$9.05
開ける：
$8.67
24時間の取引高:
3.33M
Relative Volume:
1.79
時価総額：
$484.16M
収益：
$27.46M
当期純損益:
$-46.05M
株価収益率:
-6.6667
EPS:
-1.29
ネットキャッシュフロー:
$-33.83M
1週間 パフォーマンス:
-3.15%
1か月 パフォーマンス:
-22.52%
6か月 パフォーマンス:
-0.69%
1年 パフォーマンス:
-5.81%
1日の値動き範囲:
$8.011
$8.83
1週間の範囲:
$8.011
$9.95
52週間の値動き範囲:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
名前
Zevra Therapeutics Inc
セクター
電話
(321) 939-3416
住所
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
ZVRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
8.60 | 509.49M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-08 | 再開されました | Cantor Fitzgerald | Overweight |
| 2024-10-07 | 開始されました | Guggenheim | Buy |
| 2024-09-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-09-24 | 繰り返されました | Maxim Group | Buy |
| 2024-04-02 | 繰り返されました | Maxim Group | Buy |
| 2024-03-12 | 開始されました | William Blair | Outperform |
| 2023-03-17 | 開始されました | Maxim Group | Buy |
すべてを表示
Zevra Therapeutics Inc (ZVRA) 最新ニュース
(ZVRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Will Zevra Therapeutics Inc. (1GDA) stock issue positive guidanceGlobal Markets & Daily Technical Forecast Reports - newser.com
Why Zevra Therapeutics Inc. stock could rally in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Zevra Therapeutics announces CFO transition - MSN
Zevra Therapeutics (ZVRA) CFO to Step Down, Shares Fall - GuruFocus
Zevra Therapeutics CFO Resignation Announced - TipRanks
Zevra Therapeutics, Inc. announces CFO transition - MarketScreener
Zevra Therapeutics Announces Departure of CFO R. LaDuane Clifton, Effective December 31, 2025 - Quiver Quantitative
Zevra Therapeutics, Inc. Announces Chief Financial Officer R. LaDuane Clifton to Step Down, Effective December 31, 2025 - MarketScreener
Visualizing Zevra Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock return to pre crash levelsWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic valueEarnings Beat & Safe Entry Zone Identification - newser.com
What the charts say about Zevra Therapeutics Inc. todayQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Sector Review & High Yield Stock Recommendations - newser.com
How sentiment analysis helps forecast Zevra Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - newser.com
How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsJuly 2025 Review & Consistent Profit Trade Alerts - newser.com
Can Zevra Therapeutics Inc. stock beat market expectations this quarterBuy Signal & Technical Pattern Based Signals - newser.com
Will Zevra Therapeutics Inc. stock outperform growth indexesJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Zevra Therapeutics Inc Stock Analysis and ForecastPrice-to-Earnings Ratio Insights & Free High Impact Stock Picks - earlytimes.in
How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorJuly 2025 Macro Moves & Verified Entry Point Signals - newser.com
Pattern recognition hints at Zevra Therapeutics Inc. upsideBull Run & Capital Efficient Trading Techniques - newser.com
Using Bollinger Bands to evaluate Zevra Therapeutics Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Fundamentals Check: Why Zevra Therapeutics Inc. (1GDA) stock is a must watch tickerTrade Entry Report & Verified Trade Idea Suggestions - Fundação Cultural do Pará
Why Zevra Therapeutics Inc. (1GDA) stock is a must watch tickerJuly 2025 Technicals & Safe Capital Allocation Plans - Fundação Cultural do Pará
Will Zevra Therapeutics Inc. (1GDA) stock beat revenue estimatesDividend Hike & Safe Capital Growth Stock Tips - newser.com
Why Zevra Therapeutics (ZVRA) Is Up After Achieving Profitability in Q3 Results and What’s Next - simplywall.st
Will Zevra Therapeutics Inc. (1GDA) stock beat international competitionWeekly Stock Report & Consistent Return Investment Signals - newser.com
How (ZVRA) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
Zevra Therapeutics Inc (ZVRA) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):